Data / Drug companies / Golden State Medical Supply, Inc.
Golden State Medical Supply, Inc.: 102 products in the FDA NDC directory, labeler code 60429
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Golden State Medical Supply, Inc. (labeler code 60429) lists 102 products in the FDA National Drug Code Directory, covering 46 finished drugs by generic name. By type: 99 prescription drugs, 3 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on June 30, 2021.
The request: Watch Golden State Medical Supply, Inc. (FDA labeler code 60429): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 60429
- Products in commercial distribution
- 102
- Packages
- 145
- Finished drugs by generic name
- 46
- Prescription products
- 99
- Over the counter products
- 3
- Controlled substance products
- Schedule II 1, Schedule IV 9
- Flagged as original packager
- 3 of 3 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 8
- Earliest marketing start
- August 25, 1986
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 93 | 91.2% |
| New drug applications (NDA) | 9 | 8.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 99 | 97.1% |
| Over the counter drugs | 3 | 2.9% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 40 | 39.2% |
| Tablet, film coated | 28 | 27.5% |
| Capsule | 12 | 11.8% |
| Tablet, extended release | 8 | 7.8% |
| Tablet, delayed release | 4 | 3.9% |
| Patch, extended release | 3 | 2.9% |
| Spray, metered | 2 | 2% |
| Tablet, film coated, extended release | 2 | 2% |
| Tablet, chewable | 1 | 1% |
| Solution | 1 | 1% |
| Capsule, extended release | 1 | 1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Icosapent Ethyl | 60429-005 | Capsule | Generic drugs (ANDA) | June 30, 2021 |
| Ezetimibe | 60429-982 | Tablet | Generic drugs (ANDA) | June 12, 2017 |
| Nitroglycerin | 60429-841 | Tablet | Generic drugs (ANDA) | August 26, 2016 |
| Nitroglycerin | 60429-840 | Tablet | Generic drugs (ANDA) | August 26, 2016 |
| Nitroglycerin | 60429-839 | Tablet | Generic drugs (ANDA) | August 26, 2016 |
| Mometasone furoate | 60429-664 | Spray, metered | Generic drugs (ANDA) | March 22, 2016 |
| Guanfacine Extended-Release | 60429-962 | Tablet, extended release | Generic drugs (ANDA) | June 2, 2015 |
| Guanfacine Extended-Release | 60429-961 | Tablet, extended release | Generic drugs (ANDA) | June 2, 2015 |
| Guanfacine Extended-Release | 60429-960 | Tablet, extended release | Generic drugs (ANDA) | June 2, 2015 |
| Donepezil Hydrochloride | 60429-322 | Tablet, film coated | Generic drugs (ANDA) | October 29, 2014 |
| Donepezil Hydrochloride | 60429-321 | Tablet, film coated | Generic drugs (ANDA) | October 29, 2014 |
| Pramipexole Dihydrochloride | 60429-090 | Tablet | Generic drugs (ANDA) | October 28, 2014 |
| Pramipexole Dihydrochloride | 60429-089 | Tablet | Generic drugs (ANDA) | October 28, 2014 |
| Pramipexole Dihydrochloride | 60429-088 | Tablet | Generic drugs (ANDA) | October 28, 2014 |
| Pramipexole Dihydrochloride | 60429-087 | Tablet | Generic drugs (ANDA) | October 28, 2014 |
| Pramipexole Dihydrochloride | 60429-086 | Tablet | Generic drugs (ANDA) | October 28, 2014 |
| Pramipexole Dihydrochloride | 60429-085 | Tablet | Generic drugs (ANDA) | October 28, 2014 |
| Mycophenolic Acid | 60429-017 | Tablet, delayed release | Generic drugs (ANDA) | August 19, 2014 |
| Nifedipine | 60429-049 | Tablet, extended release | Generic drugs (ANDA) | April 3, 2014 |
| Nifedipine | 60429-048 | Tablet, extended release | Generic drugs (ANDA) | April 3, 2014 |
| Nifedipine | 60429-047 | Tablet, extended release | Generic drugs (ANDA) | April 3, 2014 |
| Glycopyrrolate | 60429-666 | Tablet | Generic drugs (ANDA) | February 3, 2014 |
| Metformin hydrochloride | 60429-113 | Tablet | Generic drugs (ANDA) | September 11, 2013 |
| Metformin hydrochloride | 60429-112 | Tablet | Generic drugs (ANDA) | September 11, 2013 |
| Metformin hydrochloride | 60429-111 | Tablet | Generic drugs (ANDA) | September 11, 2013 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.